Worldwide experience with lymphatic mapping for invasive breast cancer

Solange Pendas, Rosemary Giuliano, Gray Swor, Mary Gardner, James Jakub, Douglas S. Reintgen

Research output: Contribution to journalArticlepeer-review

8 Scopus citations


Lymphatic mapping and sentinel lymph node (SLN) biopsy have changed the standard of surgical care for women with invasive breast cancer. The rate of successful axillary SLN identification varies from 90% to 99%. Recurrence rates after a negative SLN biopsy have been remarkably low. Internal mammary node drainage has been noted in 8% to 22% of cases, but whether to harvest these extra-axillary sites of drainage remains controversial. Because of the low morbidity associated with the lymphatic mapping procedure, all women with invasive breast cancer should be considered as candidates for this more accurate staging technique.

Original languageEnglish (US)
Pages (from-to)318-323
Number of pages6
JournalSeminars in oncology
Issue number3
StatePublished - Jun 2004

ASJC Scopus subject areas

  • Hematology
  • Oncology


Dive into the research topics of 'Worldwide experience with lymphatic mapping for invasive breast cancer'. Together they form a unique fingerprint.

Cite this